Woo-Dong Nam Selected Research

CT20126

7/2008

CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Woo-Dong Nam Research Topics

Disease

2	Arthritis (Polyarthritis) 07/2008 - 07/2004
2	Experimental Arthritis 07/2008 - 07/2004
2	Inflammation (Inflammations) 07/2008 - 07/2004
1	Bacterial Infections (Bacterial Infection) 03/2009
1	Rheumatoid Arthritis 07/2008

Drug/Important Bio-Agent (IBA)

2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2008 - 07/2004
2	CollagenIBA 07/2008 - 07/2004
2	NF-kappa B (NF-kB)IBA 07/2008 - 07/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2008
1	CytokinesIBA 07/2008
1	CT20126IBA 07/2008
1	ChemokinesIBA 07/2008
1	Proto-Oncogene Proteins p21(ras)IBA 07/2004
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2004
1	Farnesyltranstransferase (Farnesyltransferase)IBA 07/2004
1	Messenger RNA (mRNA)IBA 07/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004
1	LB42708IBA 07/2004